Giełda Transportu

Najnowsze Informacje ze Świata TSL

Świat

Natco Pharma up 3% on emergency approval for Baricitinib tablets for Covid-19 treatment

Natco Pharma up 3% on emergency approval for Baricitinib tablets for Covid-19 treatment

Natco Pharma was trading at ₹927.60 on the BSE


Źródło

3 May 2021, 08:14